The Big Idea
Gottfried recommends shifting from reactive disease treatment to proactive, personalized biomarker tracking across a woman’s life. By monitoring the intersections of cortisol, estrogen, progesterone, and insulin resistance across life stages, women can identify systemic root causes, interpret symptoms earlier, and support long-term brain and metabolic health.
